Epistasis as a Determinant of the HIV-1 Protease's Robustness to Mutation

被引:1
|
作者
Capel, Elena
Parera, Mariona
Angel Martinez, Miguel [1 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa, Badalona, Spain
来源
PLOS ONE | 2014年 / 9卷 / 12期
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; DELETERIOUS MUTATIONS; REVERSE-TRANSCRIPTASE; REPLICATION CAPACITY; CATALYTIC EFFICIENCY; GENETIC ROBUSTNESS; FITNESS LANDSCAPE; IN-VITRO; EVOLUTION; PROTEIN;
D O I
10.1371/journal.pone.0116301
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The robustness of phenotypes to mutation is critical to protein evolution; robustness may be an adaptive trait if it promotes evolution. We hypothesised that native proteins subjected to natural selection in vivo should be more robust than proteins generated in vitro in the absence of natural selection. We compared the mutational robustness of two human immunodeficiency virus type 1 (HIV-1) proteases with comparable catalytic efficiencies, one isolated from an infected individual and the second generated in vitro via random mutagenesis. Single mutations in the protease (82 and 60 in the wild-type and mutant backgrounds, respectively) were randomly generated in vitro and the catalytic efficiency of each mutant was determined. No differences were observed between these two protease variants when lethal, neutral, and deleterious mutations were compared (P=0.8025, chi-squared test). Similarly, average catalytic efficiency (-72.6% and -64.5%, respectively) did not significantly differ between protease mutant libraries (P=0.3414, Mann Whitney test). Overall, the two parental proteins displayed similar mutational robustness. Importantly, strong and widespread epistatic interactions were observed when the effect of the same mutation was compared in both proteases, suggesting that epistasis can be a key determinant of the robustness displayed by the in vitro generated protease.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] FLEXIBILITY AND FUNCTION IN HIV-1 PROTEASE
    NICHOLSON, LK
    YAMAZAKI, T
    TORCHIA, DA
    GRZESIEK, S
    BAX, A
    STAHL, SJ
    KAUFMAN, JD
    WINGFIELD, PT
    LAM, PYS
    JADHAV, PK
    HODGE, CN
    DOMAILLE, PJ
    CHANG, CH
    NATURE STRUCTURAL BIOLOGY, 1995, 2 (04): : 274 - 280
  • [42] AFFINITY PURIFICATION OF THE HIV-1 PROTEASE
    HEIMBACH, JC
    GARSKY, VM
    MICHELSON, SR
    DIXON, RAF
    SIGAL, IS
    DARKE, PL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 164 (03) : 955 - 960
  • [43] The structural stability of the HIV-1 protease
    Todd, MJ
    Semo, N
    Freire, E
    JOURNAL OF MOLECULAR BIOLOGY, 1998, 283 (02) : 475 - 488
  • [44] Resistance to HIV-1 protease inhibitors
    Swanstrom, R
    Smith, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 58 - BIOT
  • [45] Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease
    Davis, David A.
    Brown, Cara A.
    Singer, Kathleen E.
    Wang, Victoria
    Kaufman, Joshua
    Stahl, Stephen J.
    Wingfield, Paul
    Maeda, Kenji
    Harada, Shigeyoshi
    Yoshimura, Kazuhisa
    Kosalaraksa, Pope
    Mitsuya, Hiroaki
    Yarchoan, Robert
    ANTIVIRAL RESEARCH, 2006, 72 (02) : 89 - 99
  • [46] Computational design of mutation-resistant HIV-1 protease inhibitor libraries.
    Chellappan, S
    Gilson, MK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U804 - U804
  • [47] HIV-1 genotyping of protease and reverse-transcriptase mutation resistances in Kelantan, Malaysia
    Deris, Z. Z.
    Mohamad, S.
    Akram, T. M.
    Ariffin, T. M.
    Mustafa, M.
    Yusof, N. K.
    Chew, C. B.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S2 - S3
  • [48] Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors
    Motyan, Janos Andras
    Kassay, Norbert
    Matuz, Krisztina
    Tozser, Jozsef
    VIRUSES-BASEL, 2022, 14 (09):
  • [49] A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 protease
    Vega, S
    Kang, LW
    Velazquez-Campoy, A
    Kiso, Y
    Amzel, LM
    Freire, E
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2004, 55 (03) : 594 - 602
  • [50] HIV-1 protease mutation 82M contributes to phenotypic resistance to protease inhibitors in subtype G
    Palma, Ana Carolina
    Covens, Kris
    Snoeck, Joke
    Vandamme, Anne-Mieke
    Camacho, Ricardo Jorge
    Van Laethem, Kristel
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (05) : 1075 - 1079